Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Baxter
McKesson
McKinsey
Julphar
Federal Trade Commission
Argus Health
Deloitte
Healthtrust

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ULORIC

« Back to Dashboard

Clinical Trials for Uloric

Trial ID Title Status Sponsor Phase Summary
NCT00102440 Febuxostat Versus Allopurinol Control Trial in Subjects With Gout Completed Takeda Phase 3 The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
NCT00174915 Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. Completed Takeda Phase 3 The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
NCT00174941 Long-Term Safety of Febuxostat in Subjects With Gout. Completed Takeda Phase 2 The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD), in maintaining serum urate levels within clinically acceptable levels in subjects with gout.
NCT00174967 Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout Completed Takeda Phase 2 The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
NCT00175019 Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 Completed Takeda Phase 3 The purpose of this study is to determine the long-term safety of febuxostat, once daily (QD), compared to allopurinol in reducing serum urate levels in subjects with gout.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Uloric

Condition Name

Condition Name for Uloric
Intervention Trials
Gout 14
Hyperuricemia 4
Hypertension 3
Chronic Kidney Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Uloric
Intervention Trials
Hyperuricemia 8
Gout 8
Renal Insufficiency, Chronic 3
Kidney Diseases 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Uloric

Trials by Country

Trials by Country for Uloric
Location Trials
United States 275
Mexico 8
Canada 6
China 2
Iceland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Uloric
Location Trials
Texas 11
California 10
Florida 10
North Carolina 9
Kentucky 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Uloric

Clinical Trial Phase

Clinical Trial Phase for Uloric
Clinical Trial Phase Trials
Phase 4 5
Phase 3 6
Phase 2 11
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Uloric
Clinical Trial Phase Trials
Completed 19
Terminated 2
Not yet recruiting 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Uloric

Sponsor Name

Sponsor Name for Uloric
Sponsor Trials
Takeda 15
Shanghai 10th People's Hospital 2
Contract Research Organization: USA 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Uloric
Sponsor Trials
Industry 20
Other 18
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Dow
Mallinckrodt
Queensland Health
Cantor Fitzgerald
Argus Health
UBS
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.